Pharmaceutical Targeting of the Brain
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
5442-5462
Author(s):
István A. Krizbai, Ádám Nyúl-Tóth, Hans-Christian Bauer, Attila E. Farkas, Andreas Traweger, János Haskó, Hannelore Bauer and Imola Wilhelm
Systems Medicine Approaches to Improving Understanding, Treatment, and Clinical Management of Neuroendocrine Prostate Cancer
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
5234-5248
Author(s):
Kamlesh K. Yadav, Khader Shameer, Ben Readhead, Shalini S. Yadav, Li Li, Andrew Kasarskis, Ashutosh K. Tewari and Joel T. Dudley
The Role of Androgen Under Normal and Pathological Conditions in Sebaceous Glands: The Possibility of Target Therapy
Journal:
Current Molecular Pharmacology
Volume:
9
Page:
311-319
Author(s):
Abdullah Azmahani, Yasuhiro Nakamura, Keely M. McNamara and Hironobu Sasano
The Role of the Oxysterol/EBI2 Pathway in the Immune and Central Nervous Systems
Journal:
Current Drug Targets
Volume:
17
Page:
1851-1860
Author(s):
Aleksandra Rutkowska, Kumlesh K. Dev and Andreas W. Sailer
Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus
Journal:
Current Neuropharmacology
Volume:
14
Page:
792-804
Author(s):
Ben-Skowronek Iwona
Antidotal Effects of Curcumin Against Agents-Induced Cardiovascular Toxicity
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
16
Page:
30-37
Author(s):
Tahereh Farkhondeh and Saeed Samarghandian
Imidazo[1,2-a]pyridines: Promising Drug Candidate for Antitumor Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
16
Page:
3590-3616
Author(s):
Richa Goel, Vijay Luxami and Kamaldeep Paul
Antiangiogenics and Hypoxic Response: Role of Fatty Acid Synthase Inhibitors
Journal:
Current Drug Targets
Volume:
17
Page:
1735-1746
Author(s):
Maria Jose Bueno, Jesus Sanchez, Ramon Colomer and Miguel Quintela-Fandino
The Roles of Sox Family Genes in Sarcoma
Journal:
Current Drug Targets
Volume:
17
Page:
1761-1772
Author(s):
Jingyuan Li, Jacson Shen, Kunzheng Wang, Francis Hornicek and Zhenfeng Duan
Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
755-764
Author(s):
Senthamil R. Selvan, John P. Dowling, William K. Kelly and Jianqing Lin